Fig. 4
From: The outcome of genetic and non-genetic pediatric cardiomyopathies
a–d: Kaplan–Meier survival curve for HCM patients (a) with the multivariate assessment of the effect of the age at presentation (b), ICU admission (c), and results of the genetic study (d) on survival. The mortality rate among patients with HCM was 65%, (35 patients died), most of them in the same year of the diagnosis (First year of life). Presentation with HCM at 6 months or less and/or ICU admission was risk for mortality